NOV 01, 2022
It is with great pleasure we announce the exclusive partnership between Naslund Medical AB and MIS Healthcare for the distribution of Gold Anchor fiducial markers in the United Kingdom.
This partnership will enable more UK clinicians the opportunity to get introduced to Gold Anchor onsite. Together with MIS Healthcare we look forward to not only providing an excellent product, but also great customer support, ultimately helping medical teams provide even better care for their patients. This partnership is complementary to MIS Healthcare’s existing business and will realise many synergies for existing clients and prospects.
Huddinge, Sweden. Naslund Medical AB and MIS Healthcare announced today that the companies have entered a strategic partnership that will assist with the distribution of Gold Anchor’s superior fiducial marker across the United Kingdom. MIS Healthcare was selected as Gold Anchor fits seamlessly within their growing oncology portfolio of products and wide reach into the NHS and private practice.
The agreement brings together a market leading fiducial marker with one of the UK’s premium medical equipment, device and consumable suppliers.
“This partnership will enable more UK clinicians the opportunity to get introduced to Gold Anchor onsite. Together with MIS Healthcare we look forward to not only providing an excellent product, but also great customer support, ultimately helping medical teams provide even better care for their patients.” said Samuel Näslund, CEO Naslund Medical AB.
“This partnership is complementary to our existing business and will realise many synergies as our existing clients, and prospects, benefit from Gold Anchor’s industry leading gold marker. We look forward to the UK benefiting from Gold Anchor’s superior MRI visibility relative to other products on the market.” said Patrick Sykes, Managing Director MIS Healthcare.
UK Customers of Naslund Medical AB will purchase directly from MIS Healthcare going forward and are asked to contact MIS Healthcare for any orders or other information requirements.
About Naslund Medical AB
Naslund Medical AB is a privately held medical products company focused on the improved management and care of patients receiving radiation therapy. As the pioneer and leader in developing new technology for fiducial markers, Naslund Medical AB markets Gold Anchor worldwide. Gold Anchor enables quicker and more effective radiation therapy treatment with increased patient safety. Naslund Medical AB is based in Sweden with subsidiaries in the U.S. and France and with contracted distributors on a global level.
The Gold Anchor has been invented and developed by Ingemar Naslund, M.D, Associate Professor, working as head of the Division of Radiation Therapy, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden for 20 years, where he was one of the inventors of the SBRT technique in 1991 together with Ingmar Lax and Henric Blomgren.
About MIS Healthcare
MIS Healthcare is a UK based exclusive distributor for world leading medical manufacturers, providing state of the art products ranging from high end medical imaging diagnostic equipment, PACS/RIS, medical consumables, oncology, and diagnostic instruments. MIS Healthcare’s dedication and many years of experience have allowed them to partner with world leading manufacturers ensuring the highest levels of customer service and support whilst being committed to healthcare excellence.
MIS has an extensive customer base, which includes NHS trusts, private hospital groups, and managed equipment services providers and is an approved supplier on the NHS national supply chain framework.
MIS Healthcare’s vision is to become the market leading distribution partner of top tier suppliers across a variety of medical imaging specialisms within the UK and Ireland.
For any media queries, please contact:
Johnny Mattebo, COO Naslund Medical AB
+46 707 99 27 23
Naslund Medical AB
141 30 Huddinge
+44 208 205 9500
+44 743 610 0622
MIS Healthcare Ltd
26-27 Capitol Way